InvestorsHub Logo
Followers 2
Posts 207
Boards Moderated 0
Alias Born 07/25/2017

Re: Martygx post# 16914

Friday, 08/25/2017 12:36:06 PM

Friday, August 25, 2017 12:36:06 PM

Post# of 232961
You make reasonable points. I have not been in the prerevenue biotech market for long. But I imagine most pre-revenue companies with only one drug look like CYDY. How could they be flushed with cash? Their only way to get cash is dilution....

What poor financing decisions are you referring to? I've only been following the company since last November.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News